Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03906669
Title A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer. (WinPro)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors St. Vincent's Hospital-Manhattan
Indications

Her2-receptor negative breast cancer

Therapies

Letrozole

Tamoxifen

Age Groups: adult | senior
Covered Countries


No variant requirements are available.